Mika is a CE‑marked Class IIa digital therapeutic app that helps cancer patients track symptoms, side effects, and medication schedules while providing personalized psycho‑oncology content such as guided meditations and coping strategies. The app securely stores encrypted health data compliant with GDPR, CCPA, and HIPAA, enabling patients to share real‑time logs with their care teams to improve distress, mood, anxiety, and fatigue outcomes.
Funding
$9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients undergoing cancer treatment often experience psychological distress, depression, anxiety, and fatigue, yet lack accessible tools to monitor symptoms, manage medication schedules, and receive timely mental‑health support between clinical visits.
Solution
Mika offers a CE‑marked, Class IIa digital therapeutic app that enables cancer patients to track physical symptoms and treatment side effects in real time. The app provides automated medication reminders to help maintain adherence to complex therapy regimens. Based on the user’s cancer stage and treatment phase, Mika delivers personalized, expert‑reviewed educational content and coping resources, including guided meditations and psycho‑oncology exercises. All data are encrypted and stored in compliance with GDPR, CCPA, and HIPAA, allowing patients to share their health logs securely with their care team. Clinical studies published in peer‑reviewed journals demonstrate that Mika reduces cancer‑related distress and improves mood, anxiety, and fatigue outcomes.
Target Audience
Primary users are adult cancer patients seeking self‑management tools for symptom monitoring, medication adherence, and mental‑health support, as well as their oncologists and care teams who benefit from patient‑generated health data.
Features
- Symptom and side‑effect logging with visual trend charts for patients and clinicians
- Automated medication and appointment reminders tailored to individual treatment plans
- Personalized medical information curated by oncology experts, filtered by cancer type and therapy stage
- Psycho‑oncology modules featuring guided meditations, coping strategies, and educational videos
- CE‑certified medical device status (EU MDR 2017/745, Class IIa) and ISO 13485 quality management compliance
- Full GDPR, CCPA, and HIPAA data protection with end‑to‑end encryption and secure sharing options
- Integration pathways for clinicians to receive patient‑generated data within existing care workflows